O014/#415 Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: an NRG oncology study
Oral Abstracts (Regular and Late-Breaking Submission)(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Oral Abstracts (Regular and Late-Breaking Submission)(2022)